360 related articles for article (PubMed ID: 28134226)
1. [The evaluation of the ventricular arrhythmias and interventions of cardiac implantable electronic devices in patients with dilated cardiomyopathy for primary prevention of sudden cardiac death in ambulatory and telemetric follow-up].
Lelakowski J; Rydlewska A; Lelakowska M; Pudło J; Piekarz J
Pol Merkur Lekarski; 2017 Jan; 42(247):13-20. PubMed ID: 28134226
[TBL] [Abstract][Full Text] [Related]
2. [Safety and efficacy of classic ambulatory implantable cardioverter-defibrillator and resynchronisation systems follow-up compared to telemetric follow-up].
Lelakowski J; Rydlewska A; Piekarz J; Lelakowska-Pieła M; Pudło J
Pol Merkur Lekarski; 2016 Mar; 40(237):153-9. PubMed ID: 27088195
[TBL] [Abstract][Full Text] [Related]
3. [Ventricular arrhythmia and device intervention analysis in patients with implanted cardioverter-defibrillator with/without resynchronisation therapy in dilative cardiomyopathy in primary prevention of sudden cardiac death in telemetric follow-up].
Lelakowski J; Rydlewska A; Lelakowska M; Pudło J; Piekarz J
Przegl Lek; 2016; 73(11):830-6. PubMed ID: 29693364
[TBL] [Abstract][Full Text] [Related]
4. [Predictive parameters of occurrence of adequate interventions in patients with implanted cardioverter-defibrillators with or without resynchronisation therapy in primary prevention of sudden cardiac death in dilated cardiomyopathy].
Lelakowski J; Rydlewska A; Lelakowska M; Pudło J; Piekarz J
Pol Merkur Lekarski; 2017 Feb; 42(248):65-70. PubMed ID: 28258679
[TBL] [Abstract][Full Text] [Related]
5. [Arrhythmia, device interventions and mortality analysis in patients with implanted cardioverter-defibrillator with/without resynchronisation therapy in dilative cardiomyopathy in primary prevention of sudden cardiac death].
Lelakowski J; Pudło J; Lelakowska-Pieła M; Rydlewska A; Piekarz J; Domaracki D
Pol Merkur Lekarski; 2016 Apr; 40(238):216-22. PubMed ID: 27137820
[TBL] [Abstract][Full Text] [Related]
6. [Factors predisposing to the reprogramming of implantable cardioverter-defibrillators and the causes of changes in pharmacotherapy in patients with dilated cardiomyopathy for primary prevention of sudden cardiac death].
Pudło J; Liszniański P; Senderek T; Lelakowska-Pieła M; Lelakowski J; Nowak J
Pol Merkur Lekarski; 2015 Aug; 39(230):86-90. PubMed ID: 26319381
[TBL] [Abstract][Full Text] [Related]
7. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
8. Remote monitoring of patients with implantable cardioverter-defibrillators: can results from large clinical trials be transposed to clinical practice?
Morichau-Beauchant T; Boulé S; Guédon-Moreau L; Finat L; Botcherby EJ; Périer MC; Salleron J; Guibout C; Marquié C; Klug D; Kouakam C; Wissocque L; Brigadeau F; Lacroix D; Kacet S
Arch Cardiovasc Dis; 2014 Dec; 107(12):664-71. PubMed ID: 25241223
[TBL] [Abstract][Full Text] [Related]
9. [The assessment of factors influencing occurrence of adequate interventions of cardiac resynchronization therapy with cardioverter-defibrillator implanted in primary prevention of sudden cardiac death in dilative cardiomyopathy and percentage of biventricular pacing].
Lelakowski J; Rydlewska A; Lelakowska M; Pudło J; Piekarz J; Matusik P
Przegl Lek; 2017; 74(4):157-62. PubMed ID: 29696953
[TBL] [Abstract][Full Text] [Related]
10. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
11. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic implantable cardioverter defibrillator therapy in dilated cardiomyopathy: impact of left ventricular function.
Schaer BA; Ammann P; Sticherling C; Zellweger MJ; Cron TA; Osswald S
Int J Cardiol; 2006 Mar; 108(1):26-30. PubMed ID: 16516695
[TBL] [Abstract][Full Text] [Related]
13. Primary and secondary prevention of ventricular arrhythmias in dilated cardiomyopathy: nonsustained, sustained, and incessant.
Meyer C; Schueller P; Rodenbeck A; Hennersdorf M; Merx M; Winter J; Rassaf T; Kelm M; Schauerte P
Int Heart J; 2009 Nov; 50(6):741-51. PubMed ID: 19952471
[TBL] [Abstract][Full Text] [Related]
14. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627
[TBL] [Abstract][Full Text] [Related]
15. Day by day telemetric care of patients treated with cardiac resynchronisation therapy: first Polish experience.
Liberska A; Kowalski O; Mazurek M; Lenarczyk R; Jędrzejczyk-Patej E; Przybylska-Siedlecka K; Kozieł M; Morawski S; Podolecki T; Kowalczyk J; Pruszkowska P; Pluta S; Sokal A; Kalarus Z
Kardiol Pol; 2016; 74(8):741-748. PubMed ID: 26898970
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
[TBL] [Abstract][Full Text] [Related]
17. The impact of remote monitoring of implanted cardioverter-defibrillator (ICD) and cardiac resynchronisation therapy device (CRT-D) patients on healthcare costs in the Silesian population: three-year follow-up.
Buchta P; Tajstra M; Kurek A; Skrzypek M; Świetlińska M; Gadula-Gacek E; Wasiak M; Pyka Ł; Gąsior M
Kardiol Pol; 2017; 75(6):573-580. PubMed ID: 28150288
[TBL] [Abstract][Full Text] [Related]
18. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.
Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA
Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506
[TBL] [Abstract][Full Text] [Related]
19. Predictors of appropriate interventions and mortality in patients with implantable cardioverter-defibrillators.
Winkler A; Jaguś-Jamioła A; Uziębło-Życzkowska B; Orski Z; Krzyżanowski K; Smalc-Stasiak M; Kiliszek M
Pol Arch Intern Med; 2019 Oct; 129(10):667-672. PubMed ID: 31498300
[TBL] [Abstract][Full Text] [Related]
20. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
Zecchin M; Di Lenarda A; Proclemer A; Faganello G; Facchin D; Petz E; Sinagra G
Europace; 2004 Sep; 6(5):400-6. PubMed ID: 15294264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
